SCHEMBL8962422

SCHEMBL8962422

CC(=O)OS(=O)(=O)Nc1c(C(C)C)cccc1C(C)C

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7080904 0.86 LMNA (0.43) LMNAKMT2ASMN1; SMN2
SCHEMBL7080985 0.76
SCHEMBL8618922 0.76 SOAT2 (0.58)
SCHEMBL9386678 0.75 NLRP3 (0.47)
SCHEMBL9059769 0.75 FAAH (0.41) LMNA
SCHEMBL11234113 0.73 L3MBTL1 (0.63) LMNAKMT2ASMN1; SMN2
SCHEMBL7104643 0.73
SCHEMBL27582526 0.72 NOTUM (0.45) LMNASMN1; SMN2
SCHEMBL8941158 0.72
SCHEMBL7082105 0.72 NLRP3 (0.50) LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5491170-A TREATMENT OF HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-02-13 US disclosed
WO-1994003438-A1 SULFONAMIDE TETRAZOLE ACAT INHIBITORS WARNER-LAMBERT COMPANY (US) 1994-02-17 WO disclosed